Amrize (NYSE:AMRZ) Price Target Raised to $75.00 at Truist Financial

Amrize (NYSE:AMRZ) had its target price boosted by equities researchers at Truist Financial from $60.00 to $75.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has a “buy” rating on the stock. Truist Financial’s target price indicates a potential upside of 15.77% from the stock’s previous close.

Several other equities analysts also recently weighed in on the stock. Wall Street Zen raised shares of Amrize to a “hold” rating in a report on Saturday, October 25th. Wells Fargo & Company upped their target price on shares of Amrize from $59.00 to $66.00 and gave the stock an “overweight” rating in a report on Thursday. Bank of America set a $58.00 target price on shares of Amrize in a report on Monday, January 12th. Oppenheimer restated an “outperform” rating and issued a $70.00 price objective (up from $64.00) on shares of Amrize in a research report on Thursday. Finally, Deutsche Bank Aktiengesellschaft set a $59.00 target price on Amrize in a research report on Monday, December 8th. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, Amrize presently has an average rating of “Moderate Buy” and an average price target of $63.43.

Amrize Stock Performance

AMRZ stock traded up $0.86 during midday trading on Friday, reaching $64.78. 306,792 shares of the company’s stock traded hands, compared to its average volume of 3,467,883. The company has a current ratio of 1.45, a quick ratio of 0.97 and a debt-to-equity ratio of 0.38. Amrize has a 52-week low of $44.12 and a 52-week high of $64.83. The stock has a market cap of $35.83 billion and a P/E ratio of 35.36. The stock’s 50-day moving average is $55.91 and its 200 day moving average is $52.38.

Amrize (NYSE:AMRZ) last issued its quarterly earnings data on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.03. The business had revenue of $2.84 billion for the quarter, compared to the consensus estimate of $2.95 billion. Amrize’s revenue for the quarter was down .4% on a year-over-year basis.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Rothschild Investment LLC lifted its position in shares of Amrize by 4.3% in the 4th quarter. Rothschild Investment LLC now owns 6,835 shares of the company’s stock worth $370,000 after purchasing an additional 280 shares during the period. Baldwin Investment Management LLC lifted its holdings in Amrize by 4.4% during the fourth quarter. Baldwin Investment Management LLC now owns 8,980 shares of the company’s stock worth $486,000 after buying an additional 375 shares during the period. Itau Unibanco Holding S.A. boosted its position in Amrize by 150.0% during the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock valued at $41,000 after acquiring an additional 450 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in shares of Amrize by 141.3% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 847 shares of the company’s stock worth $46,000 after purchasing an additional 496 shares during the last quarter. Finally, MCF Advisors LLC bought a new stake in Amrize during the fourth quarter valued at about $27,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.